查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1993108

消化道出血治療器材市場：依產品類型、技術、適應症、應用和最終用戶分類－2026-2032年全球市場預測

Gastrointestinal Bleeding Treatment Devices Market by Product Type, Technology, Indication Type, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，用於治療消化道出血的設備市場價值將達到 5.9093 億美元，到 2026 年將成長到 6.2741 億美元，到 2032 年將達到 8.5929 億美元，複合年成長率為 5.49%。

主要市場統計數據
基準年 2025 5.9093億美元
預計年份：2026年 6.2741億美元
預測年份 2032 8.5929億美元
複合年成長率 (%) 5.49%

為了支持知情的策略決策，本簡要概述了影響胃腸道出血醫療設備市場趨勢的臨床、技術和商業性因素。

消化道出血仍然是一項重要的臨床挑戰，對病患預後、醫院工作流程和醫療設備創新產生重大影響。本執行摘要整合了當前影響用於診斷、控制和管理上消化道和下消化道出血的醫療設備市場的趨勢，重點介紹了對臨床醫生、醫院採購團隊和醫療技術負責人至關重要的技術進步、臨床實踐的轉變以及商業性壓力。

臨床實務、醫療設備創新和數據驅動的程序改進如何融合，從而重塑整個出血治療器材市場的治療路徑和商業模式？

治療消化道出血的器械市場正經歷一系列變革，這主要得益於器械設計、手術流程以及數據驅動的臨床支援的進步。器械符合人體工學的改進、種類更豐富的耗材以及先進的止血材料的出現，都縮短了手術時間，降低了手術複雜性，從而推動了微創內鏡治療的臨床應用範圍不斷擴大。同時，對於內視鏡治療無效的病例，放射介入和混合治療方案也日益受到重視，這體現了多學科診療模式的概念，即透過協作決策最佳化患者預後。

評估 2025 年價格調整對供應鏈的影響，以及製造商和供應商如何調整採購、庫存管理和合約以維持臨床連續性。

2025年關稅的實施和貿易政策調整給整個醫療設備供應鏈帶來了巨大壓力，尤其對用於治療消化道出血的組件和成品造成了嚴重影響。依賴跨境採購聚合物組件、特殊黏合劑和高精度電子子系統的製造商面臨更高的接收成本，被迫重新評估其地理籌資策略和庫存管理實踐。為此，一些公司加快了近岸外包的步伐，並實現了供應商多元化，以確保供應的連續性並降低進一步關稅措施的風險。

全面的細分洞察揭示了產品類型、技術方法、臨床應用、最終用戶和適應症亞型如何決定採用趨勢。

要了解消化道出血治療器材領域的臨床應用模式和產品開發重點，需要從細分市場的觀點，捕捉哪怕是最細微的差別。根據產品類型，內視鏡止血夾、止血劑、注射療法和熱療器械各自具有不同的臨床適應症和操作特性。特別是止血劑，其劑型多樣，例如粉末、片狀和噴霧劑，由於其釋放速度和表面黏附性存在差異，因此需要仔細選擇。注射療法包括酒精硬化劑、腎上腺素和聚多卡醇，每種藥物的選擇都取決於病灶的特徵和操作者的偏好。同時，氬等離子體凝固、雙極探頭和加熱探頭等熱療器械仍是靶向凝血的主要工具。

區域支付方結構、醫療服務提供者能力和人口趨勢如何影響全球醫療保健市場的需求模式差異和技術採用？

區域趨勢對全球消化道出血治療器械的進入模式、報銷途徑和技術應用有顯著影響。在美洲，一體化的醫院系統和高度整合的供應商體系創造了一個環境，​​在這種環境下，資本投資、手術量和報銷獎勵都會在採購決策中得到權衡，而私人保險公司也經常影響器械的選擇和價格談判。組織完善的臨床網路以及微創技術在展現出明確的臨床和經濟效益後能夠相對快速推廣的環境，為持續的創新循環提供了支持。

競爭對手的策略重點在於整合產品系列、臨床證據計劃和服務模式，以加速產品推廣並加強與醫療保健提供者的長期關係。

製造商之間的競爭地位日益取決於整合的產品組合、實證實踐能力和服務導向經營模式。領先的醫療設備製造商正在投資開發模組化系統，將止血劑和專用給藥裝置結合，並建立培訓和支援系統，以縮短學習曲線並加快醫院部署。醫療設備創新者與臨床研究網路之間的策略合作正在擴大真實世界數據 (REW) 的生成，從而能夠更清晰地展示流程效率和臨床結果，這些成果能夠引起臨床醫生和支付方的共鳴。

為製造商和供應商提供切實可行的策略行動，將臨床創新轉化為成功的部署，同時加強供應鏈和商業性韌性。

產業領導者應優先考慮一系列切實可行的策略，以提升臨床效用、增強營運韌性並實現商業性差異化。首先，應投資收集臨床證據，將器械使用與可衡量的結果連結起來，例如降低再出血率、縮短手術時間和降低整體治療成本。這些數據將有助於與支付方進行談判，並增強醫院的採購決策。其次，在設計醫療設備及相關系統時，應充分考慮供應鏈冗餘，以減少對單一供應商的依賴，並確保有備選方案能夠快速應對政策和物流方面的突發狀況。

採用穩健的多源方法，結合對臨床醫生的訪談、對監管和技術文件的審查以及真實世界數據 (REW) 的整合，以檢驗趨勢和見解。

本研究整合了同行評審的臨床文獻、監管文件、產品技術規範以及對臨床醫生、醫院採購經理和行業高管的訪談，從而對當前消化道出血治療器械的現狀進行了多角度的分析。研究透過對熟悉內視鏡、放射和外科出血治療的臨床醫生進行結構化訪談，收集了關鍵的定性見解；此外，還與供應鏈和採購專家進行了匿名討論，以了解採購限制和合約偏好。

整合關鍵見解，將臨床創新、供應鏈韌性和實證應用與長期的商業性和病患影響連結起來。

總之，消化道出血治療器材領域正處於臨床需求與技術機會的交會點。止血劑、精密內視鏡配件以及輔助放射學手段的進步，正在擴大臨床醫師可用的治療工具。同時，供應鏈壓力和支付方期望的改變，正在重塑產品的採購和使用方式。策略差異化將越來越依賴在特定適應症和醫療環境中證明臨床療效的能力、提供穩健的供應和服務模式的能力，以及提供可擴展的培訓以將新技術融入日常實踐的能力。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：消化道出血治療器材市場：依產品類型分類

  • 內視鏡夾
  • 止血劑
    • 粉末
    • 座位
    • 噴
  • 注射療法
    • 酒精硬化劑
    • 腎上腺素
    • 聚多卡醇
  • 熱療設備
    • 氬氣等離子凝固
    • 雙極探針
    • 加熱探針

第9章：消化道出血治療設備市場：依技術分類

  • 內視鏡
    • 軟式內視鏡
    • 硬式內視鏡
  • 放射學
    • 血管造影術導引下栓塞術
    • 腸繫膜支架
  • 外科
    • 腹腔鏡手術
    • 開放性手術

第10章：以適應症分類的消化道出血治療器械市場

  • 下消化道
    • 結腸出血
    • 直腸出血
  • 上消化道
    • 十二指腸出血
    • 食道出血
    • 胃出血

第11章：消化道出血治療設備市場：依應用領域分類

  • 血管畸形
  • 迪拉福伊病變
  • 馬洛里-韋斯撕裂傷
  • 消化性潰瘍
  • 靜脈曲張出血

第12章：消化道出血治療設備市場：依最終用戶分類

  • 門診手術中心
  • 胃腸病診所
  • 醫院（住院病人）
  • 醫院門診部

第13章：消化道出血治療器械市場：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章：消化道出血治療器材市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章：消化道出血治療器械市場：按國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國消化道出血治療器材市場

第17章：中國消化道出血治療器材市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abbott Laboratories
  • AngioDynamics, Inc.
  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • BTG International Ltd.
  • Cantel Medical Corporation
  • ConMed Corporation
  • Cook Medical LLC
  • EndoClot Plus, Inc.
  • Erbe Elektromedizin GmbH
  • FUJIFILM Holdings Corporation
  • HOYA Corporation
  • Johnson & Johnson
  • KARL STORZ SE & Co. KG
  • Medline Industries, Inc.
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • Nipro Corporation
  • Olympus Corporation
  • Ovesco Endoscopy AG
  • Smiths Group plc
  • Steris plc
  • Teleflex Incorporated
  • Terumo Corporation
Product Code: MRR-1A1A064C0286

The Gastrointestinal Bleeding Treatment Devices Market was valued at USD 590.93 million in 2025 and is projected to grow to USD 627.41 million in 2026, with a CAGR of 5.49%, reaching USD 859.29 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 590.93 million
Estimated Year [2026] USD 627.41 million
Forecast Year [2032] USD 859.29 million
CAGR (%) 5.49%

A concise orienting overview that frames clinical, technological, and commercial drivers shaping the gastrointestinal bleeding device landscape for informed strategic decision making

Gastrointestinal bleeding remains a critical clinical challenge with significant implications for patient outcomes, hospital workflows, and device innovation. This executive summary synthesizes current dynamics shaping the device landscape used to diagnose, control, and manage bleeding across upper and lower gastrointestinal tracts, emphasizing technological evolution, clinical practice shifts, and commercial pressures that matter to clinicians, hospital procurement teams, and medtech strategists.

The narrative that follows contextualizes the device ecosystem-spanning endoscopic clips, hemostatic agents, injection therapies, and thermal modalities-within the broader movement toward minimally invasive interventions and value-based care. It highlights how procedural preferences, regulatory developments, and payer behavior are influencing product adoption. Throughout, the focus remains practical: identify where clinical need intersects with technological capability and where operational constraints create opportunities for differentiated solutions.

By framing these trends against supply chain realities and emerging policy changes, the introduction sets the stage for granular segmentation, regional variances, corporate competitive positioning, and pragmatic recommendations. Readers will find an integrated view that connects clinical practice to commercial implications and provides a foundation for evidence-informed decision-making.

How converging clinical practices, device innovation, and data-driven procedural enhancements are reshaping treatment pathways and commercial models across the bleeding device landscape

The landscape for gastrointestinal bleeding treatment devices is undergoing a series of transformative shifts driven by advances in device design, procedural technique, and data-enabled clinical support. Minimally invasive endoscopic therapies continue to expand their clinical remit, supported by improvements in device ergonomics, single-use accessory options, and refined hemostatic materials that reduce procedural time and complexity. Concurrently, radiologic and hybrid approaches have gained traction for cases refractory to endoscopic care, reflecting multidisciplinary care pathways that optimize patient outcomes through collaborative decision-making.

Technological convergence is another critical vector of change, with imaging enhancements, artificial intelligence-assisted lesion detection, and integrated hemostasis delivery systems improving the precision and predictability of interventions. These developments are altering training paradigms and shifting competency expectations for endoscopists and interventional radiologists alike. At the same time, commercial dynamics-such as vendor consolidation, strategic partnerships between device manufacturers and hospital systems, and an emphasis on lifecycle cost reduction-are reshaping procurement models, encouraging bundled offerings and service-oriented contracts.

Ultimately, these transformative shifts are accelerating adoption of novel hemostatic agents and procedural adjuncts while tightening the requirements for clinical evidence and real-world outcome data that demonstrate value. The cumulative effect is a more complex but opportunity-rich marketplace where differentiated clinical performance and integrated service models will define winners.

Assessment of 2025 tariff-driven supply chain responses and how manufacturers and providers adapted sourcing, inventory, and contracting to preserve clinical continuity

The introduction of tariffs and trade policy adjustments in 2025 introduced measurable pressures across medical device supply chains, with particular relevance to components and finished devices used in gastrointestinal bleeding management. Manufacturers that rely on cross-border sourcing of polymeric components, specialized adhesives, and high-precision electrical subsystems experienced increases in landed costs that prompted reassessments of geographic sourcing strategies and inventory practices. In response, several companies accelerated nearshoring initiatives and diversified supplier bases to protect continuity of supply and mitigate exposure to additional tariff actions.

Clinical providers encountered the downstream effects of these supply chain adjustments through tighter lead times and, in some cases, temporary product reallocations across facilities. Procurement teams intensified efforts to secure contract terms that included price protection clauses and prioritized suppliers with redundant manufacturing footprints. Regulatory compliance and quality management systems emerged as decisive differentiators, as buyers favored vendors with robust documentation and validated alternative sourcing approaches that minimize disruption risk.

While tariffs contributed to short-term cost pressures, the resultant strategic responses catalyzed enduring operational changes. Manufacturers made targeted capital investments to increase domestic manufacturing capacity and implemented design modifications to reduce reliance on tariff-impacted inputs. These measures, combined with more collaborative contracting and enhanced transparency across the supply chain, are contributing to a more resilient ecosystem even as policymakers continue to assess trade frameworks.

Comprehensive segmentation insights revealing how product types, technological approaches, clinical applications, end users, and indication subtypes determine adoption dynamics

A nuanced segmentation lens is essential to understand clinical adoption patterns and product development priorities across the gastrointestinal bleeding device space. Based on product type, endoscopic clips, hemostatic agents, injection therapies, and thermal devices each carry distinct clinical indications and operational profiles; hemostatic agents warrant closer attention because they span powder, sheets, and spray formats that offer varying deployment speed and surface conformity. Injection therapy comprises alcohol sclerosant, epinephrine, and polidocanol, with each agent selected based on lesion characteristics and operator preference, while thermal devices such as argon plasma coagulation, bipolar probes, and heater probes remain core tools for targeted coagulation.

From a technology standpoint, the market intersects endoscopic, radiologic, and surgical modalities. Endoscopic approaches are further differentiated into flexible and rigid endoscopy, reflecting procedural settings and access requirements; radiologic interventions include angiographic embolization and mesenteric stenting to manage bleeding inaccessible or refractory to endoscopy; surgical approaches continue to encompass laparoscopic and open surgery when definitive anatomic control is required. Application-based segmentation-encompassing angiodysplasia, Dieulafoy lesions, Mallory-Weiss tears, peptic ulcers, and variceal bleeding-illustrates how pathology-specific device choices and clinical pathways drive clinician preferences.

End-user segmentation includes ambulatory surgical centers, gastroenterology clinics, hospital inpatient services, and hospital outpatient departments, each with different throughput, capital intensity, and procurement cycles that influence purchasing decisions. Indication type divides the domain into lower and upper GI bleeding; lower GI further differentiates into colonic and rectal bleeding, while upper GI captures duodenal, esophageal, and gastric bleeding subtypes. Together, these overlapping segmentation dimensions reveal where innovation can yield differentiated clinical value, how reimbursement and setting-of-care considerations alter uptake, and where targeted clinical evidence will most effectively support adoption.

How regional payer structures, provider capabilities, and demographic trends shape differentiated demand patterns and technology adoption across global healthcare markets

Regional dynamics materially shape access models, reimbursement pathways, and technology adoption for gastrointestinal bleeding treatment devices across the world. In the Americas, integrated hospital systems and a highly consolidated supplier base create an environment where purchasing decisions weigh capital expenditures against procedural throughput and reimbursement incentives, and private payers frequently influence device selection and pricing negotiations. Continuous innovation cycles are supported by organized clinical networks and a relatively rapid path to adoption for minimally invasive technologies, provided they demonstrate clear clinical and economic benefits.

Across Europe, the Middle East & Africa, heterogeneous healthcare financing and regulatory frameworks lead to pronounced intra-regional variation. Countries with centralized health systems emphasize cost-effectiveness and standardized treatment pathways, which can slow adoption until robust comparative-effectiveness data are available, while emerging markets within the region may prioritize durable, lower-cost solutions that simplify logistics. In contrast, the Middle East exhibits pockets of rapid technology uptake driven by targeted healthcare investments and medical tourism initiatives.

Asia-Pacific presents a dual narrative: advanced markets pursue high-end endoscopic platforms and integrated imaging solutions, whereas other jurisdictions focus on expanding access to essential hemostatic devices through decentralized care models and cost-sensitive procurement. Across the region, demographic trends and rising prevalence of anticoagulant use are increasing clinical demand, prompting greater interest in scalable devices and training programs that enable wider adoption in both hospital and outpatient settings.

Competitive narratives emphasize integrated product portfolios, clinical evidence programs, and service models that accelerate adoption and strengthen long-term provider relationships

Competitive positioning among manufacturers is increasingly defined by integrated portfolios, evidence generation capabilities, and service-oriented business models. Leading device companies are investing in modular systems that pair hemostatic agents with dedicated delivery devices, as well as in training and support frameworks that mitigate learning-curve effects and accelerate hospital onboarding. Strategic partnerships between device innovators and clinical research networks are expanding real-world evidence generation, enabling clearer demonstration of procedural efficiency gains and clinical outcomes that resonate with both clinicians and payers.

Smaller, specialized firms are carving niches through material science advances and single-use disposables optimized for specific lesion types or access routes. These focused players often deploy agile commercialization approaches, leveraging targeted clinical publications and center-of-excellence relationships to build credibility. At the same time, larger manufacturers are pursuing horizontal consolidation and licensing agreements to acquire complementary technologies, create bundled offerings, and expand geographic reach, while emphasizing compliance, manufacturing scale, and post-market surveillance as competitive advantages.

Across the ecosystem, companies that align product development with clearly articulated clinical pathways and that support adoption through hands-on training, robust clinical data, and flexible commercial terms are better positioned to capture durable relationships with high-volume centers and integrated delivery networks.

Practical strategic actions for manufacturers and providers to convert clinical innovation into reliable adoption while strengthening supply chain and commercial resilience

Industry leaders should prioritize a set of actionable strategies that address clinical utility, operational resilience, and commercial differentiation. First, invest in clinical evidence generation that links device use to measurable outcomes such as reduced rebleeding rates, shorter procedure times, and lower overall episode-of-care costs; such data support payer discussions and strengthen hospital procurement cases. Second, design devices and accessory systems with supply chain redundancy in mind, reducing reliance on single-source components and enabling rapid substitution pathways in response to policy or logistical disruptions.

Third, develop comprehensive training and proctoring programs that shorten learning curves and embed product usage into standard clinical workflows, ensuring that value propositions translate into routine practice. Fourth, pursue flexible commercial models that include managed service agreements, volume-based pricing, and bundled procurement options tailored to ambulatory, inpatient, and outpatient settings. Fifth, accelerate digital enablement by integrating device telemetry, procedural documentation, and outcomes tracking to create compelling value narratives for providers and payers alike.

Taken together, these actions will help manufacturers and health systems convert clinical innovation into sustainable adoption while protecting margins and ensuring continuity of patient care in a dynamic policy and supply chain environment.

Robust multi-source approach combining clinician interviews, regulatory and technical documentation review, and real-world evidence synthesis to validate trends and insights

This research synthesizes peer-reviewed clinical literature, regulatory filings, product technical specifications, and interviews with procedural clinicians, hospital procurement leaders, and industry executives to assemble a multi-faceted view of the gastrointestinal bleeding device landscape. Primary qualitative insights were gathered through structured interviews with clinicians experienced in endoscopic, radiologic, and surgical management of bleeding, supplemented by anonymized discussions with supply chain and purchasing professionals to understand procurement constraints and contract preferences.

Secondary research included systematic review of clinical trial repositories, device registries, and regulatory documentation to map device indications, safety profiles, and labeling changes. Product literature and real-world evidence reports were analyzed to identify procedural workflows, device compatibility considerations, and training requirements. Cross-referencing of these inputs enabled triangulation of trends and validation of emergent themes. Wherever possible, methodological transparency was maintained by documenting interview protocols, inclusion criteria for literature sources, and the process used to reconcile conflicting evidence.

Limitations of the methodology are acknowledged: evolving device introductions and ongoing post-market studies can shift the evidence base, and access to proprietary hospital procurement data was constrained by confidentiality. To mitigate these limitations, the approach emphasized diversity of sources, iterative expert validation, and explicit notation of assumptions used during synthesis.

Synthesis of critical findings that link clinical innovation, supply chain resilience, and evidence-based adoption to long-term commercial and patient impact

In summary, the gastrointestinal bleeding treatment device sector is at the intersection of clinical necessity and technological opportunity. Advances in hemostatic agents, refined endoscopic accessories, and complementary radiologic options are expanding the therapeutic toolkit available to clinicians, while supply chain pressures and shifting payer expectations are reshaping how products are purchased and used. Strategic differentiation will increasingly depend on the ability to demonstrate clinical effectiveness within specific indication and care-setting contexts, to offer resilient supply and service models, and to provide scalable training that embeds new techniques into routine practice.

Stakeholders who align product development with validated clinical pathways and who invest in the generation of meaningful real-world outcomes will be best positioned to influence procurement decisions and achieve durable market presence. The convergence of digital enablement, targeted evidence generation, and adaptive commercial strategies creates a pathway for translating device innovation into consistent clinical benefit and commercial success.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Gastrointestinal Bleeding Treatment Devices Market, by Product Type

  • 8.1. Endoscopic Clips
  • 8.2. Hemostatic Agents
    • 8.2.1. Powder
    • 8.2.2. Sheets
    • 8.2.3. Spray
  • 8.3. Injection Therapy
    • 8.3.1. Alcohol Sclerosant
    • 8.3.2. Epinephrine
    • 8.3.3. Polidocanol
  • 8.4. Thermal Devices
    • 8.4.1. Argon Plasma Coagulation
    • 8.4.2. Bipolar Probes
    • 8.4.3. Heater Probes

9. Gastrointestinal Bleeding Treatment Devices Market, by Technology

  • 9.1. Endoscopic
    • 9.1.1. Flexible Endoscopy
    • 9.1.2. Rigid Endoscopy
  • 9.2. Radiologic
    • 9.2.1. Angiographic Embolization
    • 9.2.2. Mesenteric Stenting
  • 9.3. Surgical
    • 9.3.1. Laparoscopic Surgery
    • 9.3.2. Open Surgery

10. Gastrointestinal Bleeding Treatment Devices Market, by Indication Type

  • 10.1. Lower GI
    • 10.1.1. Colonic Bleeding
    • 10.1.2. Rectal Bleeding
  • 10.2. Upper GI
    • 10.2.1. Duodenal Bleeding
    • 10.2.2. Esophageal Bleeding
    • 10.2.3. Gastric Bleeding

11. Gastrointestinal Bleeding Treatment Devices Market, by Application

  • 11.1. Angiodysplasia
  • 11.2. Dieulafoy Lesion
  • 11.3. Mallory-Weiss Tear
  • 11.4. Peptic Ulcer
  • 11.5. Variceal Bleeding

12. Gastrointestinal Bleeding Treatment Devices Market, by End User

  • 12.1. Ambulatory Surgical Centers
  • 12.2. Gastroenterology Clinics
  • 12.3. Hospitals Inpatient
  • 12.4. Hospitals Outpatient

13. Gastrointestinal Bleeding Treatment Devices Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Gastrointestinal Bleeding Treatment Devices Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Gastrointestinal Bleeding Treatment Devices Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Gastrointestinal Bleeding Treatment Devices Market

17. China Gastrointestinal Bleeding Treatment Devices Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Abbott Laboratories
  • 18.6. AngioDynamics, Inc.
  • 18.7. B. Braun Melsungen AG
  • 18.8. Boston Scientific Corporation
  • 18.9. BTG International Ltd.
  • 18.10. Cantel Medical Corporation
  • 18.11. ConMed Corporation
  • 18.12. Cook Medical LLC
  • 18.13. EndoClot Plus, Inc.
  • 18.14. Erbe Elektromedizin GmbH
  • 18.15. FUJIFILM Holdings Corporation
  • 18.16. HOYA Corporation
  • 18.17. Johnson & Johnson
  • 18.18. KARL STORZ SE & Co. KG
  • 18.19. Medline Industries, Inc.
  • 18.20. Medtronic plc
  • 18.21. Merit Medical Systems, Inc.
  • 18.22. Nipro Corporation
  • 18.23. Olympus Corporation
  • 18.24. Ovesco Endoscopy AG
  • 18.25. Smiths Group plc
  • 18.26. Steris plc
  • 18.27. Teleflex Incorporated
  • 18.28. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INDICATION TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC CLIPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC CLIPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC CLIPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HEMOSTATIC AGENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HEMOSTATIC AGENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HEMOSTATIC AGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HEMOSTATIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY POWDER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY POWDER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY POWDER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SHEETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SHEETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SHEETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SPRAY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SPRAY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SPRAY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INJECTION THERAPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INJECTION THERAPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INJECTION THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INJECTION THERAPY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ALCOHOL SCLEROSANT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ALCOHOL SCLEROSANT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ALCOHOL SCLEROSANT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY EPINEPHRINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY EPINEPHRINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY EPINEPHRINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY POLIDOCANOL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY POLIDOCANOL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY POLIDOCANOL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY THERMAL DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY THERMAL DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY THERMAL DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY THERMAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ARGON PLASMA COAGULATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ARGON PLASMA COAGULATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ARGON PLASMA COAGULATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY BIPOLAR PROBES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY BIPOLAR PROBES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY BIPOLAR PROBES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HEATER PROBES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HEATER PROBES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HEATER PROBES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY FLEXIBLE ENDOSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY FLEXIBLE ENDOSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY FLEXIBLE ENDOSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RIGID ENDOSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RIGID ENDOSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RIGID ENDOSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGIC, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ANGIOGRAPHIC EMBOLIZATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ANGIOGRAPHIC EMBOLIZATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ANGIOGRAPHIC EMBOLIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY MESENTERIC STENTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY MESENTERIC STENTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY MESENTERIC STENTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY LAPAROSCOPIC SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY LAPAROSCOPIC SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY LAPAROSCOPIC SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY OPEN SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY OPEN SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY OPEN SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY LOWER GI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY LOWER GI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY LOWER GI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY LOWER GI, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY COLONIC BLEEDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY COLONIC BLEEDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY COLONIC BLEEDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RECTAL BLEEDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RECTAL BLEEDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RECTAL BLEEDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY UPPER GI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY UPPER GI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY UPPER GI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY UPPER GI, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DUODENAL BLEEDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DUODENAL BLEEDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DUODENAL BLEEDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ESOPHAGEAL BLEEDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ESOPHAGEAL BLEEDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ESOPHAGEAL BLEEDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY GASTRIC BLEEDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY GASTRIC BLEEDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY GASTRIC BLEEDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ANGIODYSPLASIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ANGIODYSPLASIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ANGIODYSPLASIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DIEULAFOY LESION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DIEULAFOY LESION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DIEULAFOY LESION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY MALLORY-WEISS TEAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY MALLORY-WEISS TEAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY MALLORY-WEISS TEAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PEPTIC ULCER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PEPTIC ULCER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PEPTIC ULCER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY VARICEAL BLEEDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY VARICEAL BLEEDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY VARICEAL BLEEDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY GASTROENTEROLOGY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY GASTROENTEROLOGY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY GASTROENTEROLOGY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS INPATIENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS INPATIENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS INPATIENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS OUTPATIENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS OUTPATIENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS OUTPATIENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 130. AMERICAS GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 131. AMERICAS GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 132. AMERICAS GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HEMOSTATIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 133. AMERICAS GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INJECTION THERAPY, 2018-2032 (USD MILLION)
  • TABLE 134. AMERICAS GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY THERMAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 135. AMERICAS GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 136. AMERICAS GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC, 2018-2032 (USD MILLION)
  • TABLE 137. AMERICAS GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGIC, 2018-2032 (USD MILLION)
  • TABLE 138. AMERICAS GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
  • TABLE 139. AMERICAS GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. AMERICAS GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY LOWER GI, 2018-2032 (USD MILLION)
  • TABLE 141. AMERICAS GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY UPPER GI, 2018-2032 (USD MILLION)
  • TABLE 142. AMERICAS GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 143. AMERICAS GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 144. NORTH AMERICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. NORTH AMERICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. NORTH AMERICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HEMOSTATIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 147. NORTH AMERICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INJECTION THERAPY, 2018-2032 (USD MILLION)
  • TABLE 148. NORTH AMERICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY THERMAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 149. NORTH AMERICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 150. NORTH AMERICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC, 2018-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGIC, 2018-2032 (USD MILLION)
  • TABLE 152. NORTH AMERICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
  • TABLE 153. NORTH AMERICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. NORTH AMERICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY LOWER GI, 2018-2032 (USD MILLION)
  • TABLE 155. NORTH AMERICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY UPPER GI, 2018-2032 (USD MILLION)
  • TABLE 156. NORTH AMERICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 157. NORTH AMERICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 158. LATIN AMERICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 159. LATIN AMERICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. LATIN AMERICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HEMOSTATIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 161. LATIN AMERICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INJECTION THERAPY, 2018-2032 (USD MILLION)
  • TABLE 162. LATIN AMERICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY THERMAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 163. LATIN AMERICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 164. LATIN AMERICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC, 2018-2032 (USD MILLION)
  • TABLE 165. LATIN AMERICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGIC, 2018-2032 (USD MILLION)
  • TABLE 166. LATIN AMERICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 168. LATIN AMERICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY LOWER GI, 2018-2032 (USD MILLION)
  • TABLE 169. LATIN AMERICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY UPPER GI, 2018-2032 (USD MILLION)
  • TABLE 170. LATIN AMERICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 171. LATIN AMERICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HEMOSTATIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INJECTION THERAPY, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY THERMAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGIC, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY LOWER GI, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY UPPER GI, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPE GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPE GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPE GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HEMOSTATIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPE GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INJECTION THERAPY, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPE GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY THERMAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPE GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPE GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPE GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGIC, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPE GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPE GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPE GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY LOWER GI, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPE GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY UPPER GI, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPE GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPE GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 200. MIDDLE EAST GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 201. MIDDLE EAST GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 202. MIDDLE EAST GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HEMOSTATIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 203. MIDDLE EAST GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INJECTION THERAPY, 2018-2032 (USD MILLION)
  • TABLE 204. MIDDLE EAST GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY THERMAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 205. MIDDLE EAST GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 206. MIDDLE EAST GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC, 2018-2032 (USD MILLION)
  • TABLE 207. MIDDLE EAST GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGIC, 2018-2032 (USD MILLION)
  • TABLE 208. MIDDLE EAST GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 210. MIDDLE EAST GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY LOWER GI, 2018-2032 (USD MILLION)
  • TABLE 211. MIDDLE EAST GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY UPPER GI, 2018-2032 (USD MILLION)
  • TABLE 212. MIDDLE EAST GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 213. MIDDLE EAST GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 214. AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 215. AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 216. AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HEMOSTATIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 217. AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INJECTION THERAPY, 2018-2032 (USD MILLION)
  • TABLE 218. AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY THERMAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 219. AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 220. AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC, 2018-2032 (USD MILLION)
  • TABLE 221. AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGIC, 2018-2032 (USD MILLION)
  • TABLE 222. AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
  • TABLE 223. AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 224. AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY LOWER GI, 2018-2032 (USD MILLION)
  • TABLE 225. AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY UPPER GI, 2018-2032 (USD MILLION)
  • TABLE 226. AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 227. AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 228. ASIA-PACIFIC GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 229. ASIA-PACIFIC GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 230. ASIA-PACIFIC GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HEMOSTATIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 231. ASIA-PACIFIC GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INJECTION THERAPY, 2018-2032 (USD MILLION)
  • TABLE 232. ASIA-PACIFIC GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY THERMAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 233. ASIA-PACIFIC GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 234. ASIA-PACIFIC GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC, 2018-2032 (USD MILLION)
  • TABLE 235. ASIA-PACIFIC GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGIC, 2018-2032 (USD MILLION)
  • TABLE 236. ASIA-PACIFIC GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
  • TABLE 237. ASIA-PACIFIC GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 238. ASIA-PACIFIC GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY LOWER GI, 2018-2032 (USD MILLION)
  • TABLE 239. ASIA-PACIFIC GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY UPPER GI, 2018-2032 (USD MILLION)
  • TABLE 240. ASIA-PACIFIC GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 241. ASIA-PACIFIC GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 242. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 243. ASEAN GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 244. ASEAN GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 245. ASEAN GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HEMOSTATIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 246. ASEAN GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INJECTION THERAPY, 2018-2032 (USD MILLION)
  • TABLE 247. ASEAN GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY THERMAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 248. ASEAN GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 249. ASEAN GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC, 2018-2032 (USD MILLION)
  • TABLE 250. ASEAN GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGIC, 2018-2032 (USD MILLION)
  • TABLE 251. ASEAN GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
  • TABLE 252. ASEAN GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 253. ASEAN GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY LOWER GI, 2018-2032 (USD MILLION)
  • TABLE 254. ASEAN GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY UPPER GI, 2018-2032 (USD MILLION)
  • TABLE 255. ASEAN GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 256. ASEAN GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 257. GCC GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 258. GCC GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 259. GCC GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HEMOSTATIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 260. GCC GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INJECTION THERAPY, 2018-2032 (USD MILLION)
  • TABLE 261. GCC GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY THERMAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 262. GCC GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 263. GCC GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC, 2018-2032 (USD MILLION)
  • TABLE 264. GCC GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGIC, 2018-2032 (USD MILLION)
  • TABLE 265. GCC GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
  • TABLE 266. GCC GA